STEFANINI, Giulio Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 5.318
EU - Europa 1.160
AS - Asia 476
AF - Africa 181
SA - Sud America 14
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.166
Nazione #
US - Stati Uniti d'America 5.294
FI - Finlandia 363
IE - Irlanda 260
CN - Cina 243
NG - Nigeria 177
DE - Germania 106
SG - Singapore 104
SE - Svezia 102
FR - Francia 94
NL - Olanda 73
IN - India 62
IT - Italia 61
GB - Regno Unito 37
TR - Turchia 25
CA - Canada 20
BE - Belgio 18
RU - Federazione Russa 14
AU - Australia 8
IL - Israele 8
GR - Grecia 7
A2 - ???statistics.table.value.countryCode.A2??? 5
BR - Brasile 5
HK - Hong Kong 5
JP - Giappone 5
RO - Romania 5
TH - Thailandia 5
TW - Taiwan 5
ES - Italia 4
NZ - Nuova Zelanda 4
PE - Perù 4
UA - Ucraina 4
CL - Cile 3
CU - Cuba 3
PH - Filippine 3
AT - Austria 2
IR - Iran 2
MD - Moldavia 2
MY - Malesia 2
SA - Arabia Saudita 2
UG - Uganda 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
ID - Indonesia 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
ME - Montenegro 1
NO - Norvegia 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
VN - Vietnam 1
Totale 7.166
Città #
Chandler 988
Wilmington 959
San Mateo 418
Helsinki 363
Boardman 260
Dublin 259
Shanghai 235
Ann Arbor 231
Ashburn 195
Lawrence 182
Princeton 182
Benin City 177
New York 177
Leawood 148
Woodbridge 99
Singapore 96
Fairfield 91
Paris 89
Amsterdam 72
Pune 55
Los Angeles 33
Kocaeli 24
London 24
Seattle 22
Milan 21
Norwalk 20
San Diego 20
Brussels 18
Falkenstein 14
Santa Clara 14
Toronto 14
Phoenix 13
Redmond 13
Abbiategrasso 10
Redwood City 10
Des Moines 8
Moscow 6
Cambridge 5
Bangkok 4
Clearwater 4
Houston 4
Lima 4
Long Beach 4
Taipei 4
Augsburg 3
Badia Polesine 3
Gunzenhausen 3
Havana 3
Kemerovo 3
Monmouth Junction 3
Stockholm 3
Sydney 3
São Paulo 3
Athens 2
Brasília 2
Carbonara al Ticino 2
Central 2
Chisinau 2
Cupertino 2
Delhi 2
Duncan 2
Guangzhou 2
Hangzhou 2
Kampala 2
Kuala Lumpur 2
Lübeck 2
Melbourne 2
Milwaukee 2
Mykolayiv 2
Procida 2
Turin 2
Vittoria 2
Alma 1
Almaty 1
Arvada 1
Auckland 1
Azilda 1
Baltimore 1
Belgrade 1
Bilgi 1
Brescia 1
Brisbane 1
Bristol 1
Caloocan City 1
Central District 1
Chennai 1
Chicago 1
Colchester 1
Douglas 1
Dundee 1
Durban 1
Esslingen am Neckar 1
Eugene 1
Ferrara 1
Frankfurt am Main 1
Gloucester 1
Granada 1
Grand Falls-Windsor 1
Groningen 1
Hackney 1
Totale 5.682
Nome #
CAD in TAVI patients: relevance of disease complexity 63
Does clinical data quality affect fluid-structure interaction simulations of patient-specific stenotic aortic valve models? 63
On the Modeling of Patient-Specific Transcatheter Aortic Valve Replacement: A Fluid-Structure Interaction Approach 62
How should I treat a DES restenosis in a graft anastomosis with challenging access and multiple previous coronary interventions? 60
2014 ESC/EACTS Guidelines on myocardial revascularization 60
2014 ESC/EACTS Guidelines on myocardial revascularization. 59
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 59
Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary intervention. 58
Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. 57
2014 ESC/EACTS Guidelines on myocardial revascularization 57
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 57
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 57
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 56
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 56
What constitutes sufficient clinical evidence for stents? SpotLITE on the evaluation of novel coronary devices. 55
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 55
Efficacy and Safety of Calcium Channel Blocker/Diuretics Combination Therapy in Hypertensive Patients: A Meta-Analysis. 54
4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New Generation Drug-Eluting Stents in the RESOLUTE All Comers Randomized Trial. 54
Will LEADERS-FREE change my practice? A randomised double-blind comparison of the BioFreedom (TM) drug-coated stent vs. the Gazelle (TM) bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy 54
2018 ESC/EACTS Guidelines on myocardial revascularization. 54
Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation 53
2018 ESC/EACTS Guidelines on myocardial revascularization. 53
Another reason to endorse and spread guidelines 53
Clinical outcomes of bioresorbable versus durable polymer-coated everolimus-eluting stents in real-world complex patients. 52
Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease. 52
The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study 52
Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials. 52
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy 52
Coronary stents: novel developments 51
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents. 51
Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. 51
Management of ST-elevation myocardial infarction according to European and American guidelines. 50
2018 ESC/EACTS Guidelines on myocardial revascularization 50
New approach to direct stenting using a novel 'All-In-One' coronary stent system via 5 french diagnostic catheters: A pilot study 50
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 49
State of the art: coronary artery stents - past, present and future. 49
Surgical or percutaneous revascularization for isolated left anterior descending stenoses: are we in the same boat? 48
An update on drug-eluting stents versus bare-metal stents in PCI treatment: are there any remaining indications for BMS use? 48
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry. 48
The synergy stent in high-bleeding risk patients: why design matters 47
Myocardial revascularization appropriateness in Italy: measuring the unmeasured. 47
Are the culprit lesions severely stenotic? 47
Aspiration Thrombectomy for Treatment of ST-segment Elevation Myocardial Infarction: a Meta-analysis of 26 Randomized Trials in 11 943 Patients 46
What's new in the 2018 ESC/EACTS guidelines on myocardial revascularization? 45
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? Interv Cardiol. 45
Can Coronary Computed Tomography Angiography Replace Invasive Angiography? Coronary Computed Tomography Angiography Cannot Replace Invasive Angiography 45
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 45
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study. 45
Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis. 45
Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention. 44
Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials. 44
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience. 44
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials. 44
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study. 44
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement. 44
A new device for vascular embolization: report on case of two pulmonary arteriovenous fistulas embolization using the amplatzer vascular plug 44
Predictors of Adverse Events Among Patient Undergoing Primary Percutaneous Coronary Intervention - Insights From a Pooled Analysis of the COMFORTABLE-AMI and EXAMINATION trials 44
Severe aortic stenosis and coronary artery disease. 44
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study. 44
The Contemporary Pulse of Bioresorbable-Scaffold Thrombosis Among Expert Operators 43
Safety and Efficacy of Resolute Zotarolimus-Eluting Stents Compared With Everolimus-Eluting Stents A Meta-Analysis 43
Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. 42
Higher in-hospital mortality during weekend admission for acute coronary syndrome: a large-scale cross-sectional Italian study 42
Two-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stent compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry 42
Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 42
Safety and Efficacy of Polymer-Free Drug-Eluting Stents 42
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. 42
Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights from the BEAT International Collaborative Registrys 42
Drug-Eluting Coronary Artery Stents 41
Role of Niacin in current clinical practice: A systematic review 41
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial 41
Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli: The TAVI-SMALL Registry. 41
Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents A Patient-Level Pooled Analysis of Randomized Controlled Trials 41
Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation 41
Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials 40
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention Results of a Nonrandomized Observational Study 40
New-Generation Drug-Eluting Stents for Left Main In-Stent Restenosis: The DELTA-2 Registry. 40
Offline fusion of co-registered intravascular ultrasound and frequency domain optical coherence tomography images for the analysis of human atherosclerotic plaques. 40
The Valsalva maneuver in the diagnosis of patent foramen ovale. 39
The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents. 39
Clinical Outcomes and Revascularization Strategies in Patients With Low-Flow, Low-Gradient Severe Aortic Valve Stenosis According to the Assigned Treatment Modality 39
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. 39
Quantitative angiographic characterization of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention. 39
Early Doppler-echocardiography evaluation of 597 prosthetic aortic valves. 38
Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study. 38
Coronary Artery Disease Severity and Aortic Stenosis: Clinical Outcomes According to SYNTAX-Score in Patients Undergoing Transcatheter Aortic Valve Implantation 38
Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES Initiative. 38
Structure and functioning of the Heart Team: primum non nocere 38
Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration 38
Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review 38
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 38
Acute coronary syndrome in a patient with a residual aortic dissection flap after supracoronary aortic replacement: the role of intravascular ultrasound 38
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. 37
Mitral Valve Stenosis after Transcatheter Aortic Valve Replacement: Case Report and Review of the Literature. 37
Coronary artery disease in patients undergoing TAVI: why, what, when and how to treat. 37
Left atrial appendage closure with the Ultraseal device: Initial experience and mid-term follow-up. 37
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients 37
Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis 36
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial 36
Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents. 36
Totale 4.627
Categoria #
all - tutte 58.588
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.588

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 0 0 4
2020/20211.822 4 12 3 4 13 498 340 135 383 242 2 186
2021/2022905 24 10 16 246 6 2 21 149 73 68 246 44
2022/20232.901 423 110 237 316 316 209 13 217 520 288 192 60
2023/20241.823 213 147 393 116 98 264 143 126 21 49 189 64
Totale 7.455